AT THE FOREFRONT OF
CRISPR THERAPEUTICS DEVELOPMENT
OUR TECHNOLOGY
Directly addressing the inherent limitations of current CRISPR methodologies, our technology seeks to unlock previously unattainable avenues in the development of CRISPR based therapeutics.
TECHNOLOGICAL FEATURES
Unprecedented
Homology-Directed
Repair Rates
Accounts for
Immunogenicity
Unique
RNP Delivery
Validated
CRISPR Nuclease
"WHAT WILL REPLACE Cas9 IS A HIGH FREQUENCY PRECISION EDITING HDR METHODOLOGY"
PROF. GEORGE CHURCH, CRISPR PIONEER
FIND OUT MORE.I
CONTACT US.
AddressIn
Institut NEOMED
7171 Frederick Banting
Saint-Laurent H4S 1Z9
(Québec) Canada